Genesis Therapeutics

Genesis Therapeutics is a company that leverages artificial intelligence (AI) and proprietary technologies to accelerate drug discovery and design. They have developed a unique platform known as PotentialNet, a molecular graph deep learning method, which aids in the prediction of molecular properties and the generation of new, optimized molecules. The company's goal is to improve the efficiency of drug discovery, making it quicker and more cost-effective to bring new treatments to patients.

The team at Genesis Therapeutics is comprised of experts in machine learning, computational chemistry, and drug discovery, who work collaboratively to create AI-driven solutions. Their approach allows for more accurate predictions and the ability to tackle complex drug discovery challenges. With the help of their technology, the company aims to bring effective and safe new medicines to the market quicker, improving the health and lives of patients worldwide.